Published in
Lippincott, Williams & Wilkins, Melanoma Research, 5(28), p. 465-468, 2018
DOI: 10.1097/cmr.0000000000000458
Links
Tools
Early onset of diffuse melanosis cutis under pembrolizumab therapy illustrates the limitations of anti-PD-1 checkpoint inhibitors:
Journal article published in 2018 by
Alexander Thiem,
Patrick Schummer,
Simon Ueberschaar,
Andreas Kerstan,
Hermann Kneitz,
David Schrama,
Silke Appenzeller 
,
Svenja Meierjohann,
Bastian Schilling,
Matthias Goebeler,
Anja Gesierich
,
Svenja Meierjohann,
Bastian Schilling,
Matthias Goebeler,
Anja Gesierich
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 